Celldex Therapeutics reported $-79.72M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
AbbVie USD 6.91B 3.22B Jun/2026
Agenus USD -10.11M 19.02M Mar/2025
Amgen USD 5.8B 1.25B Sep/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Celldex Therapeutics USD -79.72M 3.86M Jun/2026
Glaxosmithkline GBP 2.93B 154M Sep/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Pfizer USD 6.36B 350M Sep/2026
Rigel Pharmaceuticals USD -4.17M 798K Sep/2023
Roche Holding CHF 13.43B 744M Jun/2026